The regulation of EVs in the immune system, reducing T-cell activity, promotes tumor immune escape via programmed cell death protein-1 (PD-1) and its ligands via a programmed-death-ligand-1 (PD-L1)-related pathway. This evidence concerns the gene PDCD1 and neoplasm.